Julio Rosenstock, MD is Director of the Dallas Diabetes Research Center at Medical City, and Clinical Professor of Medicine at the University of Texas Southwestern Medical Center, Dallas.
He received his MD from the University of Costa Rica School of Medicine and completed fellowships in Endocrinology and Diabetes at the Royal Postgraduate Medical School, Hammersmith Hospital, London, UK, and at the University of Texas Southwestern Medical Center. He is board certified in Internal Medicine, and Endocrinology and Metabolism.
His clinical and research activities have focused on exploring novel agents and therapeutic strategies to improve glycemic control, particularly early insulin intervention with combination strategies in Type 2 Diabetes helping to develop the concept of fixed-ratio combination of Basal Insulin with a GLP-1 RA. Over the last 30 years, he has participated in hundreds of clinical trials and has had an active role in the development of new oral agents and insulin preparations acting often as a lead clinical investigator and scientific advisor.
Dr Rosenstock has been the author or co-author of more than 470 publications, including peer-reviewed papers and numerous abstracts. He has also contributed to several clinics and book chapters on various topics in the field of diabetes. He is currently Associate Editor of Diabetes Care, an Editorial Board member of Practical Diabetology and Cardiovascular Diabetology and is an active reviewer for several journals. Dr Rosenstock has chaired or been a featured speaker at multiple lectures and presentations both nationally and internationally.